Sotac Pharmaceuticals Ltd share price logo

Sotac Pharmaceuticals Ltd

NSE: SOTAC

Small Cap

Pharma Sector

₹111.65

+5.30

(+4.98%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Sotac Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-35%

Searches for Sotac Pharmaceuticals on INDmoney have decreased by 35% over the last 30 days.

Key Events for Sotac Pharmaceuticals

Last Dividend Declared

₹0.20 per share, declared on 26/05/2026

View Dividend History

Sotac Pharmaceuticals Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • ₹111.65
    ₹111.65

  • 52 Week's Low

    52 Week's High

    ₹86.00
    ₹139.65
    downward going graph

    22.97%

    Downside

    25.08%

    Upside

    downward going graph

Sotac Pharmaceuticals share price movements today

Previous Close
₹106.35
Open
₹111.65
Volume
1,200.00
Upper Circuit
₹111.65
Lower Circuit
₹101.05
Day's Low - High
₹111.65 - ₹111.65
52 Week Low - High
₹86.00 - ₹139.65

Sotac Pharmaceuticals Historical Returns

1 Month Return
+ 18.1 %
3 Month Return
+ 15.66 %
1 Year Return
-17.56 %
3 Year Return
-14.92 %
5 Year Return
-11.93 %

Sotac Pharmaceuticals Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹123.37 Cr

Return on Equity (ROE)

8.88

PE Ratio (TTM)

18.3

Return on capital employed (ROCE)

12.19

Industry PE ratio

51.65

Beta (LTM)

0.08

P/B Ratio

2.09

Dividend Yield

0

PEG Ratio

12.8

Quarterly Earnings Growth YOY

0

EPS (TTM)

5.7

Book Value

53.28

Sotac Pharmaceuticals Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Sotac Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (4.86x)

April 24, 2023

Today (18.30x)

October 29, 2026

Industry (51.65x)

October 29, 2026

Highest (30.59x)

December 8, 2023

LowHigh

Today’s Price to Earnings Ratio: 18.30x

Sotac Pharmaceuticals Technical Analysis

Track how Sotac Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish2
Neutral9

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
-66.67
Neutral
RSI (14)
100
Bearish
Momentum (10)
0
Neutral
ADI (14)
100
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
111.65
Neutral
EMA (20)
111.65
Neutral
VWMA (20)
111.65
Neutral
SMA (50)
111.65
Neutral
EMA (50)
111.65
Bullish
SMA (200)
111.65
Neutral
EMA (200)
110.66
Bullish
KAMA (200)
111.65
Neutral
DEMA (200)
113.1
Bearish

Sotac Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sotac Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA123.37-2.39%0.716101
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY703.856.04%0.6229235
Coral Laboratories Ltd image
Coral Laboratories Ltd
NA172.918.06%0.001685
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA41.35-0.31%0.00535
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA137.0817.94%0.004105
See all

Sotac Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Sales
25.74
26.45
25.25
27.35
Other Income
0.61
0.35
0.25
0.45
Total Income
26.35
26.8
25.5
27.8
Expenses
23.06
25.27
23.03
25.24
Operating Profit
2.68
1.18
2.22
2.11
Operating Profit Margin %
10.41%
4.46%
8.79%
7.71%
Profit Before Interest, Tax and Depreciation
3.29
1.53
2.46
2.56
Interest
0.99
0.35
0.42
0.6
Depreciation
0.83
0.88
0.75
0.74
Profit Before Tax
1.47
0.3
1.29
1.22
Tax Paid
0.59
-1.21
-0.05
0.79
Profit After Tax
0.88
1.51
1.35
0.42
Total Net profit including share of profit / Loss from associate company
0.91
1.65
1.46
0.46
EPS
0.82
1.49
1.32
0.42
Actual EPS
0.82
1.49
1.32
0.42
Adjusted EPS
0.82
1.49
1.32
0.42
Diluted EPS
0.82
1.49
1.32
-

Sotac Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
28.6
48.84
77.48
103.83
99.74
101.24
Other Income
0.22
0.11
0.93
0.49
1.15
0.35
Total Income
28.83
48.95
78.41
104.32
100.88
101.59
Expenses
26.74
47.39
70.23
95.55
83.35
83.36
Operating Profit
1.86
1.45
7.25
8.28
16.39
17.88
Operating Profit Margin %
6.5%
2.97%
9.36%
7.97%
16.43%
17.66%
Profit Before Interest, Tax and Depreciation
2.08
1.56
8.18
8.77
17.53
18.23
Interest
0.33
1.02
1.98
1.7
2.58
4.13
Depreciation
1.4
2.59
2.28
3.1
3.84
5.41
Profit Before Tax
0.35
-2.05
3.92
3.97
11.11
8.69
Tax Paid
0.27
0.31
1.64
0.39
1.85
2.4
Profit After Tax
0.09
-2.37
2.29
3.58
9.28
6.29
Total Net profit including share of profit / Loss from associate company
0.09
-2.37
2.88
4.28
8.03
5.76
EPS
0.89
-10.28
3.58
3.9
7.26
5.22
Actual EPS
0.89
-10.28
3.58
3.9
7.26
5.22
Adjusted EPS
0.25
-2.94
3.58
3.9
7.26
5.22
Diluted EPS
0.89
-10.28
3.58
3.9
7.26
5.22

Sotac Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
0.06
-0.31
8.14
-16.08
-4.35
16.85
Cash Flow from Investing Activities
-11.75
-3.23
-11.67
-14.59
-18.55
-5.39
Cash Flow from Financing Activities
11.4
3.38
13.14
29.49
16.11
-10.34
Net Cash Flow
-0.29
-0.16
9.61
-6.26
-1.85
-0.39

Sotac Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Mar 2024
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Promoters
72.85%
72.85%
72.85%
72.85%
72.85%
72.85%
FII
0%
0%
0%
0%
16.79%
16.46%
Public
18.16%
18.27%
11.35%
11.01%
10.36%
10.69%
Total Outstanding Shares
1,10,50,000
1,10,50,000
1,10,50,000
1,10,50,000
1,10,50,000
1,10,50,000
Total Shareholders
245
251
243
240
221
230

Sotac Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Sotac Pharmaceuticals.

  • Sotac Pharmaceuticals Ltd Earnings Results

    Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.

    Read More

  • Sotac Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, Sotac Pharmaceuticals Ltd has declared dividend of ₹0.20 per share on 26 May 2026 - translating a dividend yield of 0.19%.

    Read More about Dividends

Insights on Sotac Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 16.14% to 16.79% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SOTAC stock has moved up by 10.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.85% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 11.01% to 10.36% in Mar 2026 quarter

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited is a part of the Gujarat based SOTAC Group, offering a range of products such as tablets, capsules, oral liquids, and external preparations. Their therapeutic portfolio includes options for treating ailments such as diabetes, psychotics, vitamins, minerals, cold, allergies, ulcers, and more. They started off as a Partnership Firm in October 2015 and have since then evolved into a Public Limited Company. Their installed capacity for manufacturing is 90 crore tables and 14 crore capsules per year. In 2022, they acquired two subsidiary companies and started a new venture called SOTAC Lifescience Private Limited, raising 51 percent of total paid-up capital. They are planning to come out with a Initial Public Offer consisting of up to 3 million equity shares through a fresh issue.

Revenue: ₹27.35Cr as on September 2024 (Q2 FY25)
Net Profit: ₹0.42Cr as on September 2024 (Q2 FY25)
Listing date: 13 Apr, 2023
Chairperson Name: Sharadkumar Dashrathbhai Patel
OrganisationSotac Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOSharadkumar Dashrathbhai Patel
E-voting on sharesClick here to vote

FAQs

What is Sotac Pharmaceuticals share price today?

Sotac Pharmaceuticals share price today stands at ₹111.65 as on at the close of the market. Sotac Pharmaceuticals share today touched a day high of ₹111.65 and a low of ₹111.65.

What is the 52 week high and 52 week low range for Sotac Pharmaceuticals share?

Sotac Pharmaceuticals touched a 52 week high of ₹139.65 and a 52 week low of ₹86. Sotac Pharmaceuticals share price today i.e. is closed at ₹111.65, which is -20.05% down from its 52 week high and 29.83% up from its 52 week low.

What is Sotac Pharmaceuticals's market capitalisation today?

Sotac Pharmaceuticals market capitalisation is ₹123.37 Cr as on .

How to buy Sotac Pharmaceuticals shares?

To buy Sotac Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SOTAC or Sotac Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sotac Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sotac Pharmaceuticals trading volume today?

Sotac Pharmaceuticals trading volume is 1,200.00 as on . This means that 1,200.00 shares of Sotac Pharmaceuticals were bought and sold on the stock market during today's trading session.